It was already a bad enough week for the Prime Minister Sir Keir Starmer and the Chancellor Rachel Reeves, what with the collapse of their welfare reforms. But now news has leaked that AstraZeneca’s CEO Sir Pascal Soriot has reportedly discussed moving its listing from London to New York. There is nothing official yet, and no decision has been made. But for the boss of Britain’s most valuable listed company to even contemplate upping sticks spells trouble for the UK economy.

It is not hard to blame him. Over-regulation has turned the London market into a relative backwater. Meanwhile, Wall Street........

© The Spectator